CervoMed Inc.
CRVO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18,891 | $20,303 | $3,933 | $30,272 |
| - Cash | $8,999 | $7,793 | $4,094 | $37,314 |
| + Debt | $0 | $0 | $12,414 | $10,025 |
| Enterprise Value | $9,891 | $12,511 | $12,253 | $2,983 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$18,227 | -$7,813 | -$5,802 | -$15,945 |
| % Margin | – | – | – | – |
| Net Income | -$16,291 | -$2,172 | -$5,803 | -$24,096 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.02 | -0.82 | -11.2 | -18.51 |
| % Growth | -146.3% | 92.7% | 39.5% | – |
| Operating Cash Flow | -$16,531 | -$7,450 | -$2,573 | -$14,502 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$16,531 | -$7,450 | -$2,573 | -$14,502 |